Not applicableStudy completedNCT04048850What this trial is testingZepatier in Patients with Substance UseWho this might be right forHepatitis CHivCoinfection, HIV+1 more University of Illinois at Chicago 25
Large-scale testing (Phase 3)Study completedNCT04155515What this trial is testingA Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I PatientsWho this might be right forChronic Hepatics C Virus (HCV) Genotype 1Non-CirrhoticCirrhosis+1 more Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 370
Testing effectiveness (Phase 2)Study completedNCT01464827What this trial is testingABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected PatientsWho this might be right forChronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1 AbbVie (prior sponsor, Abbott) 580
Testing effectiveness (Phase 2)Study completedNCT01057667What this trial is testingRO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 168
Post-approval studies (Phase 4)Study completedNCT00394277What this trial is testingInduction Dosing With PEGASYS (Peginterferon Alfa-2a [40KD]) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis CWho this might be right forHepatitis C, Chronic Hoffmann-La Roche 1,175
Large-scale testing (Phase 3)Study completedNCT00237484What this trial is testingEffect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 89
Large-scale testing (Phase 3)Study completedNCT03833362What this trial is testingEfficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study)Who this might be right forHepatitis C R-Pharm 420
Testing effectiveness (Phase 2)Study completedNCT00996476What this trial is testingAssess the Effectiveness, Safety, and Pharmacokinetics of TMC435 in Combination With Peginterferon Alfa-2a and Ribavirin in Hepatitis-C Infected PatientsWho this might be right forHepatitis C, Chronic Janssen Pharmaceutical K.K. 92
Not applicableStudy completedNCT01750216What this trial is testingAn Observational Study of Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) on Predictive Values of RVR on Sustained Virological Response in Different Stages of Liver Fibrosis in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 196
Not applicableEnded earlyNCT01465516What this trial is testingTreating Hispanic Patients Diagnosed With Hepatitis C Using BoceprevirWho this might be right forHepatitis C Infection Arrowhead Regional Medical Center 105
Early research (Phase 1)Study completedNCT00529321What this trial is testingImmunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C VirusWho this might be right forHepatitis C, Chronic Transgene 42
Testing effectiveness (Phase 2)UnknownNCT00332176What this trial is testingEvaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis CWho this might be right forChronic Hepatitis C BioWest Therapeutics Inc 50
Testing effectiveness (Phase 2)Study completedNCT00446134What this trial is testingTaribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)Who this might be right forChronic Hepatitis C Bausch Health Americas, Inc. 278
Large-scale testing (Phase 3)Study completedNCT00265395What this trial is testingExtended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 1,428
Testing effectiveness (Phase 2)Study completedNCT00517439What this trial is testingHepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 516
Not applicableStudy completedNCT03002818What this trial is testingQuality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)Who this might be right forChronic Hepatitis C Virus (HCV) AbbVie 41
Large-scale testing (Phase 3)Ended earlyNCT00423800What this trial is testingEfficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 56
Not applicableStudy completedNCT00854802What this trial is testingDebio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 PatientsWho this might be right forChronic Hepatitis C Debiopharm International SA 290
Testing effectiveness (Phase 2)Study completedNCT01055821What this trial is testingEfficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV PatientsWho this might be right forChronic Hepatitis C Infection Transgene 140
Testing effectiveness (Phase 2)Study completedNCT00978497What this trial is testingSafety, Tolerability, and Antiviral Activity of ANA598 Administered in Combination With Pegylated Interferon and Ribavirin for the Treatment of Genotype-1 Chronic HCV InfectionWho this might be right forHCV Infection Hoffmann-La Roche 97